|

Acolbifene Hydrochloride Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Breast Lobular Carcinoma In Situ1
  • Breast Atypical Hyperplasia1
  • Breast Carcinoma1
  • Breast Ductal Carcinoma In Situ1
  • Breast Cancer1

Duarte, California1 trial

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

City of Hope Comprehensive Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.